🇺🇸 FDA
Patent

US 7662568

Immunoliposome-nucleic acid amplification (ILNAA) assay

granted A61KA61K9/127

Quick answer

US patent 7662568 (Immunoliposome-nucleic acid amplification (ILNAA) assay) held by The United States of America as represented by the Secretary of the Army expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K9/127